From: Immune parameters associated with survival in metaplastic breast cancer
 | PDL1 in tumor | PDL1 in stromal | PD1 in tumor | PD1 in stromal |
---|---|---|---|---|
TILs (> 300/mm2) | Rho 0.131 | Rho 0.193 | Rho 0.118 | Rho 0.12 |
p | 0.33 | 0.17 | 0.38 | 0.38 |
CD4 + TILs(> 250/mm2) | Rho 0.149 | Rho 0.094 | Rho 0.178 | Rho 0.125 |
p | 0.26 | 0.51 | 0.18 | 0.36 |
CD8+ TILs (> 70/mm2) | Rho 0.492 | Rho 0.367 | Rho −0.018 | Rho 0.128 |
p | < 0.001 | 0.006 | 0.89 | 0.34 |
CD68+ TILs (> 300/mm2) | Rho 0.1 | Rho − 0.053 | Rho 0.018 | Rho 0.015 |
p | 0.45 | 0.71 | 0.89 | 0.91 |
TILs percentage (> 20%) | Rho − 0.034 | Rho 0 | Rho − 0.016 | Rho − 0.165 |
p | 0.80 | 1 | 0.42 | 0.22 |